XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.20.4

Equity | 12 Months Ended
--- | ---
Dec. 31, 2020
Equity [Abstract] |
Equity | Equity Common Stock Dividends—The following table summarizes the common stock dividends declared during the period (in thousands):
|  |  | Year Ended December 31,
|  |  |  |  | 2020 |  | 2019 |  | 2018
Common stock dividends declared |  |  |  |  | $ | — |  |  | $21,302 |  | $ | 20,695 |
Claw back of dividends on cancelled Performance Stock Units |  |  |  |  | (202) |  |  | — |  | — |
8.25% Series D Cumulative Preferred Stock—At December 31, 2020 and 2019, there were 1.6 million shares of 8.25% Series D cumulative preferred stock outstanding. The Series D cumulative preferred stock ranks senior to all classes or series of the Company’s common stock and future junior securities, on a parity with each series of the Company’s outstanding preferred stock (the Series B cumulative convertible preferred stock) and with any future parity securities and junior to future senior securities and to all of the Company’s existing and future indebtedness, with respect to the payment of dividends and the distribution of amounts upon liquidation, dissolution or winding up of the Company’s affairs. Series D cumulative preferred stock has no maturity date, and we are not required to redeem the shares at any time. Series D cumulative preferred stock is redeemable at our option for cash (on or after November 20, 2023), in whole or from time to time in part, at a redemption price of $25.00 per share plus accrued and unpaid dividends, if any, at the redemption date. Series D cumulative preferred stock may be converted into shares of our common stock, at the option of the holder, in certain limited circumstances such as a change of control. Each share of Series D cumulative preferred stock is convertible into a maximum 5.12295 shares of our common stock. The actual number is based on a formula as defined in the Series D cumulative preferred stock agreement (unless the Company exercises its right to redeem the Series D cumulative preferred shares for cash, for a limited period upon a change in control). The necessary conditions to convert the Series D cumulative preferred stock to common stock have not been met as of period end. Therefore, Series D cumulative preferred stock will not impact our earnings per share. Series D cumulative preferred stock quarterly dividends are set at the rate of 8.25% of the $25.00 liquidation preference (equivalent to an annual dividend rate of $2.0625 per share). In general, Series D cumulative preferred stock holders have no voting rights. The Series D Cumulative Preferred Stock dividend for all issued and outstanding shares is set at $2.0625 per annum per share. The following table summarizes dividends declared (in thousands):
|  |  | Year Ended December 31, |
|  |  |  |  | 2020 |  | 2019 |  | 2018 |
Series D Cumulative Preferred Stock |  |  |  |  | $ | 3,300 |  |  | $ | 3,300 |  |  | $ | 376 |  |
Stock Repurchases—On October 27, 2014, our board of directors approved a share repurchase program under which the Company may purchase up to $100 million of the Company’s common stock from time to time. The repurchase program does not have an expiration date. The specific timing, manner, price, amount and other terms of the repurchases is at management’s discretion and depends on market conditions, corporate and regulatory requirements and other factors. The Company is not required to repurchase shares under the repurchase program, and may modify, suspend or terminate the repurchase program at any time for any reason. On December 5, 2017, our board of directors reapproved the stock repurchase program pursuant to which the board of directors granted a repurchase authorization to acquire shares of the Company’s common stock, par value $0.01 per share having an aggregate value of up to $50 million. The board of directors’ authorization replaced any previous repurchase authorizations. No shares were repurchased during the years ended December 31, 2020, 2019 and 2018. As of December 31, 2020, $50 million remains authorized by the board of directors pursuant to the December 5, 2017 approval. We repurchased approximately 47,000, 45,000 and 31,000 shares of our common stock in 2020, 2019 and 2018, respectively, to satisfy employees’ statutory minimum U.S. federal income tax obligations in connection with vesting of equity grants issued under our stock-based compensation plan. At-the-Market Common Stock Equity Distribution Program—On December 11, 2017, the Company established an “at-the-market” equity distribution program pursuant to which it may, from time to time, sell shares of its common stock having an aggregate offering price of up to $50 million. As of December 31, 2020, the Company has sold approximately 4.7 million shares of common stock and received proceeds of approximately $14.5 million under this program. The issuance activity is summarized below (in thousands):
|  |  | Year Ended December 31, |  |
|  |  | 2020 |  |
Common shares issued |  |  | 4,729 |  |  |
Gross proceeds received |  |  | $ | 14,717 |  |  |
Commissions and other expenses |  |  | 184 |  |  |
Net proceeds |  |  | $ | 14,533 |  |  |
Noncontrolling Interest in Consolidated Entities—A partner had noncontrolling ownership interests of 25% in two hotel properties with a total carrying value of $(15.1) million and $(6.0) million at December 31, 2020 and 2019, respectively. The following table summarizes the (income) loss allocated to noncontrolling interest in consolidated entities (in thousands):
|  |  |  | Year Ended December 31,
|  |  |  |  |  | 2020 |  | 2019 |  | 2018
(Income) loss from consolidated entities attributable to noncontrolling interests |  |  |  |  |  | $ | 6,436 |  |  | $ | (2,032) |  |  | $ | (2,016) |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration